Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 18, 2007
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy
Marco Volante, Maria Pia Brizzi, Antongiulio Faggiano, et al.
Virchows Archiv : an International Journal of Pathology
|
July 3, 2019
ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature
Stefano La Rosa, Marco Volante, Silvia Uccella, et al.
Oncotarget
|
February 18, 2016
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
Marco Lo Iacono, Consuelo Buttigliero, Valentina Monica, et al.
Neuroendocrinology
|
January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas
Lindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Cancer Letters
|
February 22, 2019
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase
Iacopo Gesmundo, Laura Di Blasio, Dana Banfi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 22, 2019
Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors
Salvatore Grisanti, Angelina Filice, Vittoria Basile, et al.
British Journal of Cancer
|
October 7, 2020
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
Mohammad Aarif Siddiqui, Paradesi Naidu Gollavilli, Vignesh Ramesh, et al.
Endocrine-Related Cancer
|
April 23, 2017
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer
Elisa Roca, Alfredo Berruti, Silviu Sbiera, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 2, 2014
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series
Lindsey Oudijk, Ronald R de Krijger, Ida Rapa, et al.
European Journal of Endocrinology
|
October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
Deborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 18, 2007
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy
Marco Volante, Maria Pia Brizzi, Antongiulio Faggiano, et al.
Virchows Archiv : an International Journal of Pathology
|
July 3, 2019
ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature
Stefano La Rosa, Marco Volante, Silvia Uccella, et al.
Oncotarget
|
February 18, 2016
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
Marco Lo Iacono, Consuelo Buttigliero, Valentina Monica, et al.
Neuroendocrinology
|
January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas
Lindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Cancer Letters
|
February 22, 2019
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase
Iacopo Gesmundo, Laura Di Blasio, Dana Banfi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 22, 2019
Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors
Salvatore Grisanti, Angelina Filice, Vittoria Basile, et al.
British Journal of Cancer
|
October 7, 2020
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
Mohammad Aarif Siddiqui, Paradesi Naidu Gollavilli, Vignesh Ramesh, et al.
Endocrine-Related Cancer
|
April 23, 2017
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer
Elisa Roca, Alfredo Berruti, Silviu Sbiera, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 2, 2014
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series
Lindsey Oudijk, Ronald R de Krijger, Ida Rapa, et al.
European Journal of Endocrinology
|
October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
Deborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Page
of 7